Nephrology Doctors in Paducah, KY Accepting Medicare

5 Nephrology doctors found. Showing 1 - 5

Eric Scowden, M.D. Internal Medicine - Nephrology Medicare: Not Enrolled in Medicare Practice Location: 1532 Lone Oak Rd, Paducah, KY 42003 Phone: 270-538-5880    Fax: 270-538-5880

Dr. Jonathan David Wilkerson, M.D. Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1532 Lone Oak Rd, Suite 315, Paducah, KY 42003 Phone: 270-538-5880    Fax: 287-538-5870

Hisham Abu Farsak, Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1532 Lone Oak Rd Ste 315, Paducah, KY 42003 Phone: 270-538-5880    Fax: 270-538-5870

Shaukat Ali, M.D. Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 1532 Lone Oak Rd, Suite 315, Paducah, KY 42003 Phone: 270-538-5880    Fax: 270-538-5870

Steven J Mccullough, DO Internal Medicine - Nephrology Medicare: Accepting Medicare Assignments Practice Location: 225 Medical Center Dr, Suite 304, Paducah, KY 42003 Phone: 270-538-5596    Fax: 270-538-5597

News Archive

Researchers develop new strategy for treating the most aggressive type of brain cancer

Researchers from the University of São Paulo in Brazil have developed a strategy for treating the most aggressive type of brain cancer in adults that combines a photoactive molecule and a chemotherapeutic agent - both encapsulated in protein-lipid nanoparticles.

Calchan, Galapagos partner to discover and develop novel target for osteoarthritic pain

Calchan Holdings Limited, a UK company focused on the development of novel medicines based on calcium ion channel modulators, and Galapagos NV, a clinical stage biotech company focused on developing novel mode of action medicines, today announce that they have entered into a research collaboration in the area of osteoarthritis pain.

New treatment improves visual acuity score of patients with retinitis pigmentosa

Neurotech SA announced positive results from an open-label Phase I clinical trial (03-EI-0234) of its lead product, NT-501. NT-501 uses Neurotech's patented Encapsulated Cell Technology (ECT) as a device to deliver ciliary neurotrophic factor (CNTF) to eyes of visually impaired patients with retinitis pigmentosa (RP). Neurotech is a biotechnology company specializing in the development of novel therapeutics to treat diseases of the eye. The company is headquartered in Paris.

Efficacy data of Caldolor Injection in treating fever associated with falciparum malaria published

Cumberland Pharmaceuticals Inc. today announced that data supporting the efficacy of Caldolor in treating fever associated with falciparum malaria was published in the July edition of the peer-reviewed American Journal of Tropical Medicine and Hygiene. The study, which is the first to document an antipyretic effect of an injectable non-steroidal anti-inflammatory drug on fever caused by malaria, demonstrated that patients who received intravenous ibuprofen experienced a greater reduction in their temperatures than those who received placebo.

Study provides treatment guidance for children and adolescents with multisystem inflammatory syndrome

An analysis conducted by a group of investigators including Tamara Bradford, MD, Associate Professor of Pediatrics at LSU Health New Orleans School of Medicine, found that children and adolescents with Multisystem inflammatory syndrome in children (MIS-C) initially treated with intravenous immune globulin (IVIG) plus glucocorticoids had a lower risk of new or persistent cardiovascular dysfunction than IVIG alone.

Read more Medical News

› Verified 9 days ago